or Try an Advanced Search...

    Technical Analysis for PRFX - PainReform Ltd.

    Grade Last Price % Change Price Change
    C 1.04 -25.71% -0.36
    PRFX closed down 25.71 percent on Wednesday, November 20, 2024, on 1.17 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical PRFX trend table...
    Date Alert Name Type % Chg
    Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Gapped Down Weakness 0.00%
    Crossed Above 20 DMA Bullish -25.71%
    Crossed Above 50 DMA Bullish -25.71%
    MACD Bullish Centerline Cross Bullish -25.71%
    Expansion Breakout Bullish Swing Setup -25.71%
    Older End-of-Day Signals for PRFX ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 18 hours ago
    2x Volume Pace about 22 hours ago
    1.5x Volume Pace about 22 hours ago
    3x Volume Pace about 22 hours ago
    5x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PRFX Chart by TradingView
    Basic chart:

    Profile

    PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Pharmacy Opioids Pharmaceutical Sciences Hepatotoxins Nonsteroidal Anti Inflammatory Drug

    Is PRFX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
    Nov 20 PainReform drops on late-stage trial data for post-surgical pain management after bunionectomy
    Nov 20 PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
    Nov 7 PainReform receives Nasdaq notice regarding minimum stockholders’ equity requirement
    Nov 7 PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
    Oct 25 PainReform cut to Hold at Maxim amid ‘changed’ market dynamics
    Sep 23 Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Sep 11 PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
    Sep 10 Top Midday Decliners
    Sep 10 PainReform Shares Are Trading Lower Today: What's Going On
    See more PRFX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.16
    52 Week Low 0.4318
    Average Volume 4,329,538
    200-Day Moving Average 4.50
    50-Day Moving Average 0.66
    20-Day Moving Average 0.62
    10-Day Moving Average 0.69
    Average True Range 0.18
    RSI (14) 61.83
    ADX 21.4
    +DI 54.24
    -DI 6.91
    Chandelier Exit (Long, 3 ATRs) 1.27
    Chandelier Exit (Short, 3 ATRs) 0.98
    Upper Bollinger Bands 1.05
    Lower Bollinger Band 0.19
    Percent B (%b) 0.99
    BandWidth 137.56
    MACD Line 0.05
    MACD Signal Line -0.03
    MACD Histogram 0.0746
    Fundamentals Value
    Market Cap 2.11 Million
    Num Shares 2.03 Million
    EPS -6.64
    Price-to-Earnings (P/E) Ratio -0.16
    Price-to-Sales 0.00
    Price-to-Book 0.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.31
    Resistance 3 (R3) 1.32 1.23 1.26
    Resistance 2 (R2) 1.23 1.16 1.23 1.25
    Resistance 1 (R1) 1.14 1.12 1.10 1.13 1.23
    Pivot Point 1.05 1.05 1.03 1.05 1.05
    Support 1 (S1) 0.96 0.99 0.92 0.95 0.85
    Support 2 (S2) 0.87 0.94 0.87 0.83
    Support 3 (S3) 0.78 0.87 0.82
    Support 4 (S4) 0.77